AQST vs MSCI · rev $28.3M vs P/E 37, rev $1.72B
Aquestive Therapeutics Inc (AQST) versus MSCI Inc (MSCI) — a side-by-side from cached financials, not a winner call.
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
Latest reported AQST revenue for 2026-06-30 was $28.3M. Net income was -$30.9M. Revenue was up 95.7% from 2026-03-31 to 2026-06-30. AQST currently screens at market cap $493.0M.
Latest reported MSCI revenue for 2026-06-30 was $1.72B. Net income was $748.0M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
AQST currently screens at market cap $493.0M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Not investment advice. Open the AQST and MSCI stock pages for the full models.
Not investment advice.